173 related articles for article (PubMed ID: 19417369)
1. Multiplex detection of breast cancer biomarkers using plasmonic molecular sentinel nanoprobes.
Wang HN; Vo-Dinh T
Nanotechnology; 2009 Feb; 20(6):065101. PubMed ID: 19417369
[TBL] [Abstract][Full Text] [Related]
2. Multiplex detection of disease biomarkers using SERS molecular sentinel-on-chip.
Ngo HT; Wang HN; Burke T; Ginsburg GS; Vo-Dinh T
Anal Bioanal Chem; 2014 May; 406(14):3335-44. PubMed ID: 24577572
[TBL] [Abstract][Full Text] [Related]
3. Multicolor Cocktail for Breast Cancer Multiplex Phenotype Targeting and Diagnosis Using Bioorthogonal Surface-Enhanced Raman Scattering Nanoprobes.
Wang J; Liang D; Feng J; Tang X
Anal Chem; 2019 Sep; 91(17):11045-11054. PubMed ID: 31361124
[TBL] [Abstract][Full Text] [Related]
4. Surface-enhanced Raman scattering molecular sentinel nanoprobes for viral infection diagnostics.
Wang HN; Fales AM; Zaas AK; Woods CW; Burke T; Ginsburg GS; Vo-Dinh T
Anal Chim Acta; 2013 Jul; 786():153-8. PubMed ID: 23790305
[TBL] [Abstract][Full Text] [Related]
5. Ki67 in breast cancer: a useful prognostic marker?
Caldarella A; Crocetti E; Paci E
Ann Oncol; 2014 Feb; 25(2):542. PubMed ID: 24412822
[No Abstract] [Full Text] [Related]
6. Reply to Ki67 in breast cancer: a useful prognostic marker!
Denkert C; von Minckwitz G
Ann Oncol; 2014 Feb; 25(2):542-3. PubMed ID: 24431345
[No Abstract] [Full Text] [Related]
7. Plasmonics nanoprobes: detection of single-nucleotide polymorphisms in the breast cancer BRCA1 gene.
Wabuyele MB; Yan F; Vo-Dinh T
Anal Bioanal Chem; 2010 Sep; 398(2):729-36. PubMed ID: 20676618
[TBL] [Abstract][Full Text] [Related]
8. Application prospective of nanoprobes with MRI and FI dual-modality imaging on breast cancer stem cells in tumor.
Chen H; Wang Y; Wang T; Shi D; Sun Z; Xia C; Wang B
J Nanobiotechnology; 2016 Jun; 14(1):52. PubMed ID: 27339420
[TBL] [Abstract][Full Text] [Related]
9. Direct and Label-Free Detection of MicroRNA Cancer Biomarkers using SERS-Based Plasmonic Coupling Interference (PCI) Nanoprobes.
Wang HN; Crawford BM; Norton SJ; Vo-Dinh T
J Phys Chem B; 2019 Dec; 123(48):10245-10251. PubMed ID: 31710234
[TBL] [Abstract][Full Text] [Related]
10. Plasmonic nanoprobes: from chemical sensing to medical diagnostics and therapy.
Vo-Dinh T; Fales AM; Griffin GD; Khoury CG; Liu Y; Ngo H; Norton SJ; Register JK; Wang HN; Yuan H
Nanoscale; 2013 Nov; 5(21):10127-40. PubMed ID: 24056945
[TBL] [Abstract][Full Text] [Related]
11. Rapid and sensitive phenotypic marker detection on breast cancer cells using surface-enhanced Raman scattering (SERS) imaging.
Lee S; Chon H; Lee J; Ko J; Chung BH; Lim DW; Choo J
Biosens Bioelectron; 2014 Jan; 51():238-43. PubMed ID: 23973735
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-Raman dual modal endoscopic system for multiplexed molecular diagnostics.
Jeong S; Kim YI; Kang H; Kim G; Cha MG; Chang H; Jung KO; Kim YH; Jun BH; Hwang DW; Lee YS; Youn H; Lee YS; Kang KW; Lee DS; Jeong DH
Sci Rep; 2015 Mar; 5():9455. PubMed ID: 25820115
[TBL] [Abstract][Full Text] [Related]
13. Quantitative and Specific Detection of Exosomal miRNAs for Accurate Diagnosis of Breast Cancer Using a Surface-Enhanced Raman Scattering Sensor Based on Plasmonic Head-Flocked Gold Nanopillars.
Lee JU; Kim WH; Lee HS; Park KH; Sim SJ
Small; 2019 Apr; 15(17):e1804968. PubMed ID: 30828996
[TBL] [Abstract][Full Text] [Related]
14. Label-free, in situ SERS monitoring of individual DNA hybridization in microfluidics.
Qi J; Zeng J; Zhao F; Lin SH; Raja B; Strych U; Willson RC; Shih WC
Nanoscale; 2014 Aug; 6(15):8521-6. PubMed ID: 24953169
[TBL] [Abstract][Full Text] [Related]
15. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
Laible M; Schlombs K; Kaiser K; Veltrup E; Herlein S; Lakis S; Stöhr R; Eidt S; Hartmann A; Wirtz RM; Sahin U
BMC Cancer; 2016 Jul; 16():398. PubMed ID: 27389414
[TBL] [Abstract][Full Text] [Related]
16. Molecular sentinel-on-chip for SERS-based biosensing.
Wang HN; Dhawan A; Du Y; Batchelor D; Leonard DN; Misra V; Vo-Dinh T
Phys Chem Chem Phys; 2013 Apr; 15(16):6008-6015. PubMed ID: 23493773
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in the management of breast cancer: great expectations, hard times.
Bertelli G; Nelmes DJ; Al-Allak A
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):481-4. PubMed ID: 24220569
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor, human epidermal growth factor receptor-2, and Ki-67 status in primary breast cancer and corresponding recurrences or synchronous axillary lymph node metastases.
Yamanouchi K; Kuba S; Eguchi S
Surg Today; 2020 Jul; 50(7):657-663. PubMed ID: 31190183
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors for Luminal B-like Breast Cancer.
Ding NH; Liu CF; Hu C; Yuan JQ; Liao WH; Xiao Z
Curr Med Sci; 2019 Jun; 39(3):396-402. PubMed ID: 31209809
[TBL] [Abstract][Full Text] [Related]
20. An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.
Varga Z; Lebeau A; Bu H; Hartmann A; Penault-Llorca F; Guerini-Rocco E; Schraml P; Symmans F; Stoehr R; Teng X; Turzynski A; von Wasielewski R; Gürtler C; Laible M; Schlombs K; Joensuu H; Keller T; Sinn P; Sahin U; Bartlett J; Viale G
Breast Cancer Res; 2017 May; 19(1):55. PubMed ID: 28490348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
